Studies also showed that one-third of patients taking Wegovy maintained weight loss of20% at two years
We built Noom GLP-1 Companion with Muscle Defense to be that program, said Geoff Cook, Chief Executive Officer of Noom, which is why we are so excited for this integration
[Open access] (Source: BJOG) Prescription distribution and inequities in diabetes care: A comparative analysis of CGM access by diabetes status, ethnicity and socio-economic factors in England Significant CGM prescribing disparities exist, with Afro-Caribbean and South Asian populations receiving fewer prescriptions
The dose will also depend on whether the drug is being prescribed to manage type 2 diabetes or to promote weight loss in people with obesity
S., Vijayalakshmi M
What ongoing review should cover How much weight you have lost and over what period Whether side effects are settling, persisting or worsening Whether the current dose is right, or whether staying longer is better than escalating Any new symptoms, particularly abdominal pain Any new medicines you have started Whether your other conditions or medicines need reviewing as your weight changes Your eating pattern, protein intake and activity Do you need blood tests
